Short answer
PRO DEX INC (PDEX) filed its Q3 2025 10-Q quarterly report on Oct 30, 2025 for the quarter ended Sep 30, 2025. Quarterly revenue was $19M (up 24.4% year over year) with net income of $5M.
Q3 2025 key financials · XBRL
- Revenue
- $19M
- +24.4% YoY
- Net income
- $5M
- +89.8% YoY
- Operating margin
- 16.8%
- Gross margin
- 29.0%
- EPS (diluted)
- $1.40
- +86.7% YoY
Source: XBRL data from the PRO DEX INC (PDEX) Q3 2025 10-Q on SEC EDGAR. USD.
PRO DEX INC Q3 2025 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $18.530M, up 24% YoY from $14.892M
- Operating margin 17% vs 20% YoY; gross margin 29% vs 35%
- Best segment orthopedic sales $11.053M, up 65%; worst thoracic sales $501K, down 51%
- Cash $514K, up $95K; operating cash flow $2.310M; loan principal payments $2.2M
- Outlook: backlog $46.8M; Helios production expected Q2; tariffs and repair costs pressuring margins
Risk Factors
- New AI misinformation risk triggered by August 2025 securities-law-firm release linking stale filings to a 20% stock-price decline
- New ticker-confusion risk triggered by Polkadex trading under PDEX on certain crypto exchanges
- Regulatory risk from potential shareholder confusion involving unrelated Polkadex and Pro-Dex securities
- Market risk from possible mistaken cryptocurrency or Pro-Dex stock trades
- No material changes to fiscal 2025 10-K risks beyond the two added factors
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other PRO DEX INC quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.